On Friday, Clover Health Investments Corp (NASDAQ: CLOV) opened higher 1.94% from the last session, before settling in for the closing price of $4.12. Price fluctuations for CLOV have ranged from $0.61 to $4.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 52.25%. Company’s average yearly earnings per share was noted 68.61% at the time writing. With a float of $372.47 million, this company’s outstanding shares have now reached $393.27 million.
The extent of productivity of a business whose workforce counts for 552 workers is very important to gauge. In terms of profitability, gross margin is 18.33%, operating margin of -7.26%, and the pretax margin is -7.57%.
Clover Health Investments Corp (CLOV) Insider Updates
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of Clover Health Investments Corp is 25.13%, while institutional ownership is 14.86%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.
Clover Health Investments Corp (CLOV) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 68.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.10% during the next five years compared to -585.84% drop over the previous five years of trading.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Check out the current performance indicators for Clover Health Investments Corp (CLOV). In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.15 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
The latest stats from [Clover Health Investments Corp, CLOV] show that its last 5-days average volume of 5.39 million was inferior to 8.0 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 71.05%. Additionally, its Average True Range was 0.24.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 86.25%, which indicates a significant increase from 51.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.28% in the past 14 days, which was lower than the 96.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.38, while its 200-day Moving Average is $1.71. Now, the first resistance to watch is $4.29. This is followed by the second major resistance level at $4.39. The third major resistance level sits at $4.47. If the price goes on to break the first support level at $4.11, it is likely to go to the next support level at $4.03. Assuming the price breaks the second support level, the third support level stands at $3.93.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
There are currently 497,469K shares outstanding in the company with a market cap of 2.13 billion. Presently, the company’s annual sales total 2,034 M according to its annual income of -213,360 K. Last quarter, the company’s sales amounted to 356,260 K and its income totaled 7,410 K.
